Schedule 13G ownership disclosure

MEDI JECT CORP /MN/

Security class unavailable · CUSIP: 036642106

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
11,472,832
Percent of class
7.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000834237-20-004581
Form type
SC 13G/A
Filer
ANTARES PHARMA, INC.
CIK
CIK 1016169
Filed
Feb 05, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub